Treatment of therapy resistant Alopecia areata with fumaric acid esters (Fumaderm® and Fumaderm initial®) – an open, single center, non-randomized, pilot study with 40 patients

Registry ID

EUCTR2011-000659-18

Source registry

EUCTR

Status

Ongoing

Phase

PHASE2

Sponsor

University Hospital Tübingen

Start date

2011-08-22

Last update

2026-08-16

Conditions

• Alopecia areata

Summary

Evaluation of the therapeutic efficacy defined as the average improvement of the patient’s SALT score at week 24 from baseline.

Locations

• , , Germany

Related clinical trials

• Skin diseases and the association with addictive diseases

View on source registry